Live Industry Supported Symposium at the National Lipid Association 2017 Scientific Sessions

  • May 18, 2017
    6:45 pm - 9:00 pm

Target Audience

Cardiologists, Lipidologists, and other healthcare professionals responsible for the diagnosis, treatment or management of patients with dyslipidemia.

Learning Objectives

  1. Review advances in LDL-C science and the role of LDL-C in CVD prevention
  2. Understand the current ACC/AHA/ESC/NLA guidelines for the management of patients with dyslipidemia.
  3. Analyze extended CVD Outcomes clinical trial data for PCSK9 inhibitor therapeutics.
  4. Apply newer scientific knowledge and data into personalized treatment plans for patients with statin intolerance, familial hypercholesterolemia, and dyslipidemia patients not at LDL-C goal.



Grand Ballroom BCD, 1201 Market St., Philadelphia, Pennsylvania, 19107, United States